Other
2019
Nagy B. Campbell J.D. Kaló Z (eds): The role of modelling in economic evaluations in health care. Eötvös University Press. 2019. ISBN 978-963-489-119-2
2016
Agh T, Inotai A: Patient Reported Outcomes. Principles of Measurement and Applicability in Economic Evaluation (e-book). Eötvös Loránd University, Faculty of Social Sciences, Budapest, 2016. ISBN: 978-963-284-747-4.
2014
Inotai A, Lovas K, Kalo Z (eds). [Patient Reported Outcomes]. SprindMed Kiado, Budapest, 2014. [in Hungarian] ISBN: 978-963-9695-15-3
2012
Kalo Z, Meresz G, Mezei D, Tótth A, Inotai A: The grounding and implications of Szell Kalman Plan [Full Report, in Hungarian, based on the paper: Kalo et al.: IME, 2012; 11:6,12-16].
2011
Inotai A: Pharmacoeconomic aspects of oral nonsteroidal antiinflammatory drugs in rheumatoid arthritis focusing on the selective COX-2 inhibitor celecoxib. PhD thesis (2011)
2010
Kalo Z, Inotai A, Lukovics M: Health Economic Syllabus II. Economic Analysis of Health Market, Finance and Investment. Budapest, Professional Publishing Hungary Kft. Medical Tribune, 2010
2009
Nagy B: Risk adjustment for the allocation of health care resources in Hungary - development of the capitation payment formula. PhD thesis (2009)
Rozsa S, Brandtmuller A, Nagy B, Brennan A, Akehurst R: The psychometric properties of ADCS - Activities of Daily Living Inventory and comparison of different ADL scores. ScHARR Discussion papers 2009, No. 09/05
Kalo Z, Inotai A, Nagyjanosi L. Health Economic Syllabus I. Economic Analysis of Health Technologies. Budapest, Professional Publishing Hungary Kft. Medical Tribune, 2009
2008
Kalo, Z., Docteur, E. and Moïse, P: Pharmaceutical pricing and reimbursement policies in Slovakia, OECD Health Working Paper, No. 31, Paris. 2008 Link
Voko Z, Adany R: Driving Improved Health Intelligence In: Wismar M, McKee, M Ernst K, Srivastava D, Busse R (szerk.) Health targets in Europe: Learning from experience Kopenhagen: WHO Regional Publications, 2008. p. 137-147. (Observatory studies series; 13.)
